Peter F. Aziz et al. JACEP 2015;1:62-70

Slides:

Advertisements

Similar presentations

Oana Dickinson et al. JACEP 2016;2:

Advertisements

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:

Noriko Kikuchi et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:

Marwan Badri et al. JACEP 2015;1:

Takekuni Hayashi et al. JACEP 2016;2:27-35

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Waddah Maskoun et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:

Pablo Ávila et al. JACEP 2015;1:

Chin-Yu Lin et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:89-96

Junjie Zhang et al. JACEP 2017;j.jacep

Masatoshi Yamazaki et al. JACEP 2015;1:

Tom F. Brouwer et al. JACEP 2016;2:

Junjie Zhang et al. JACEP 2017;3:

Alexander Sedaghat et al. JACEP 2017;3:71-75

Tom F. Brouwer et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Pablo B. Nery et al. JACEP 2016;2:

Songyun Wang et al. JACEP 2016;2:97-106

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Patrick M. Boyle et al. JACEP 2018;4:

Junjie Zhang et al. JACEP 2017;3:

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Jong Sung Park et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;3:

Prakash Harikrishnan et al. JACEP 2015;1:

Giuseppe Boriani et al. JACEP 2016;2:

Mohit K. Turagam et al. JACEP 2017;3:

Prabhat Kumar et al. JACEP 2016;j.jacep

Eran Leshem et al. JACEP 2018;j.jacep

Moussa Mansour et al. JACEP 2017;3:

Mintu P. Turakhia et al. JACEP 2016;2:

Leonard M. Rademakers et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

Konstantinos C. Siontis et al. JACEP 2016;2:

Mitsunori Maruyama et al. JACEP 2017;3:

K.R. Julian Chun et al. JACEP 2017;3:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Vivek Y. Reddy et al. JACEP 2016;2:

Yoshitaka Kimura et al. JACEP 2016;2:

Emilce Trucco et al. JACEP 2018;j.jacep

Marwan Badri et al. JACEP 2015;1:

Vittorio Calzolari et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;j.jacep

Eran Leshem et al. JACEP 2018;j.jacep

Moussa Mansour et al. JACEP 2016;j.jacep

Stuart A. Ostby et al. JACEP 2016;2:

Alexander Sedaghat et al. JACEP 2016;j.jacep

Ayman A. Hussein et al. JACEP 2017;3:1-9

Mintu P. Turakhia et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;3:

Simon W. Rabkin et al. JACEP 2017;3:

Emilce Trucco et al. JACEP 2018;j.jacep

K.R. Julian Chun et al. JACEP 2017;3:

Noboru Ichihara et al. JACEP 2016;2:

Aya Miyazaki et al. JACEP 2016;2:

Björn Redfors et al. JACEP 2017;j.jacep

Matthew M. Zipse et al. JACEP 2015;1:94-102

Bernard Lim et al. JACEP 2016;2:

Adam B. Greenbaum et al. JACEP 2015;1:

Eran Leshem et al. JACEP 2018;j.jacep

Daniele Muser et al. JACEP 2017;j.jacep

Miyako Igarashi et al. JACEP 2018;4:

Maria R. Costanzo et al. JCHF 2016;4:

Presentation transcript:

Peter F. Aziz et al. JACEP 2015;1:62-70 Bethesda Classification (Competitive Athletes as Well as LQT1 Subtype) (A) Sports classified in accordance with the Bethesda Guidelines. Increasing static component (I-III) is depicted on the y-axis and increasing dynamic component (A–C) is depicted on the x-axis. (B) Sports classified for long QT1 (LQT1) patients in accordance with Bethesda guidelines. This figure shows a proportionate distribution of LQT1 athletes compared to Figure 2. Peter F. Aziz et al. JACEP 2015;1:62-70 American College of Cardiology Foundation